Hu, Yo, and Ri Antibodies with Reflex to Titers and Western Blot

Test Code
90138


CPT Codes
86255 (x3)

Includes
Hu Antibody Screen with Reflex to Titer and Western Blot
Yo Antibody Screen with Reflex to Titer and Western Blot
Ri Antibody Screen with Reflex to Titer and Western Blot

If Hu Antibody Screen, IFA is Positive, then Hu Antibody, WB will be performed at an additional charge (CPT code(s): 84181).
If Hu Antibody, WB is Positive, then Hu Antibody, Titer will be performed at an additional charge (CPT code(s): 86256).

If Yo Antibody Screen, IFA is Positive, Yo Antibody, WB will be performed at an additional charge (CPT code(s): 84181).
If Yo Antibody, WB is Positive, then Yo Antibody, Titer will be performed at an additional charge (CPT code(s): 86256).

If Ri Antibody Screen, IFA is Positive, then Ri Antibody, Western Blot will be performed at an additional charge (CPT code(s): 84181).
If Ri Antibody, Western Blot is Positive, then Ri Antibody, Titer will be performed at an additional charge (CPT code(s): 86256).


Preferred Specimen
1.5 mL serum


Patient Preparation
Overnight fasting is preferred

Minimum Volume
0.6 mL


Transport Container
Transport tube


Transport Temperature
Room temperature


Specimen Stability
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 21 days


Methodology
Immunofluorescence Assay (IFA)

FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Setup Schedule
Set up: Mon, Wed, Fri; Report Available: 3 days


Reference Range
See Laboratory Report


Clinical Significance
Hu anti-neuronal nuclear antibody (anti-Hu) is found in 5-10% of patients with small cell carcinoma of the lung. Purkinje cell (Yo) antibody is found in patients with paraneoplastic cerebellar degeneration and is associated with breast, ovarian, and other gynecologic cancers. Some patients with ovarian cancer have low titers of Yo antibodies in the absence of cerebellar degeneration. Anti-Hu antibodies are associated with paraneoplastic encephalomyelitis and sensory neuropathy. Anti-Ri antibody can be detected in patients with paraneoplastic opsoclonus/myoclonus syndrome. Neoplasms most often associated with anti-Ri include breast cancer, small cell lung cancer, and gynecological cancers.




The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.